Evidence map›Paper›PMID 35052978›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Colistin Resistance Mechanisms in Human

Daniela Fortini, Slawomir Owczarek, Anna Maria Dionisi, Claudia Lucarelli, Sergio Arena, Alessandra Carattoli, Enter-Net Italia Colistin Resistance Study Group, Laura Villa, Aurora García-Fernández

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Antibiotic-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Polymyxin Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Characterization ofFrontiers in microbiology · 2024
    Article
  9. Article
  10. The Prolonged Treatment ofInternational journal of molecular sciences · 2023
    Article
  11. Genomic characterization ofFrontiers in microbiology · 2023
    Article
  12. A Familiar Outbreak of MonophasicPathogens (Basel, Switzerland) · 2022
    Article
  13. The Occurrence and Genomic Characteristics ofFoods (Basel, Switzerland) · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Daniela FortiniDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Slawomir OwczarekDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Anna Maria DionisiDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Claudia LucarelliDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Sergio ArenaDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
Alessandra CarattoliDepartment of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Enter-Net Italia Colistin Resistance Study Group
Laura VillaDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-7380-7097
Aurora García-FernándezDepartment of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-5070-6154
Istituto Superiore di Sanità · ITSapienza University of Rome · IT

Funding

Italian Ministry of Health RF-2018-12366604
6 · The paper itself

Abstract

backgroundA collection of human-epidemiologically unrelated

methodsAntimicrobial susceptibility tests, including the determination of minimal inhibitory concentrations (MICs) for colistin, were performed. Colistin resistant strains were analysed by PCR to detect mobile colistin resistance (

resultsThe prevalence of colistin-resistant

conclusionsThe colistin national surveillance in

Indexed as

antibiotic resistancecolistinEnteritidisIncHI2IncX4mcrSalmonellaTyphimuriumzoonosis

Identifiers

PMID35052978
PMCPMC8772777
OpenAlexW4205678598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.